| Target Price | HK$39.17 |
| Price | HK$24.70 |
| Potential |
58.57%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Giant Biogene Holding Co 2027 .
The average Giant Biogene Holding Co target price is HK$39.17.
This is
58.57%
register free of charge
HK$77.41
213.38%
register free of charge
HK$25.25
2.23%
register free of charge
|
|
| A rating was issued by 28 analysts: 23 Analysts recommend Giant Biogene Holding Co to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Giant Biogene Holding Co stock has an average upside potential 2027 of
58.57%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 6.45 | 7.32 |
| 0.37% | 13.49% | |
| EBITDA Margin | 40.23% | 36.31% |
| 5.56% | 9.75% | |
| Net Margin | 34.70% | 31.55% |
| 6.81% | 9.07% |
22 Analysts have issued a sales forecast Giant Biogene Holding Co 2026 . The average Giant Biogene Holding Co sales estimate is
This results in the following potential growth metrics:
21 Giant Biogene Holding Co Analysts have issued a net profit forecast 2026. The average Giant Biogene Holding Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 2.11 | 2.17 |
| 12.45% | 2.84% | |
| P/E | 11.36 | |
| EV/Sales | 2.31 |
21 Analysts have issued a Giant Biogene Holding Co forecast for earnings per share. The average Giant Biogene Holding Co EPS is
This results in the following potential growth metrics and future valuations:
Giant Biogene Holding Co...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


